This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Scientists have developed a vaccine against a notorious drug-resistant superbug, targeting molecules on its surface that are also found on other bacteria and fungi.
Credit: Purdue University photo/Mark Simons Your gut bacteria could say a lot about you, such as why you’re diabetic or how you respond to certain drugs. But scientists can see only so much of the gastrointestinal tract to study the role of gut bacteria in your health. What comes out of you is just a […].
Traditional folk remedies in rural Italy inspired the research Credit: Quave Lab Scientists isolated a molecule, extracted from the leaves of the European chestnut tree, with the power to neutralize dangerous, drug-resistant staph bacteria. Frontiers in Pharmacology published the finding, led by scientists at Emory University.
Process paves a road to safe, ethical, and fast drug manufacturing Credit: Rensselaer Polytechnic Institute TROY, N.Y. — Envisioning an animal-free drug supply, scientists have — for the first time — reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals.
— Scientists at Cornell University have created cell-size robots that can be powered and steered by ultrasound waves. Despite their tiny size, these micro-robotic swimmers – whose movements were inspired by bacteria and sperm – could one day be a formidable new tool for targeted drug delivery. ITHACA, N.Y.
Washington, DC – June 20, 2021 – Researchers from the Miami University in Ohio have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria.
In the fight against multidrug-resistant bacteria, scientists in Sweden have developed a new kind of antibiotic-free protection for wounds that kills drug-resistant bacteria and induces the body’s own immune responses to fight infections.
Credit: University of Groningen Bacteria in the small intestine can deaminate levodopa, the main drug that is used to treat Parkinson’s disease. Bacterial processing of the unabsorbed fractions of the drug results in a metabolite that reduces gut motility.
A new genetic approach can accelerate the study of phage-microbe interactions with implications for health, agriculture, and climate Credit: Wikimedia Commons Scientists are continually searching for new and improved ways to deal with bacteria, be it to eliminate disease-causing strains or to modify potentially beneficial strains.
Columbia Engineering researchers report that they have developed a “cloaking” system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer cells in mice. Using Bacteria For Therapy. ” The Ideal Bacteria.
Potential new antibiotics work by disrupting bacterial membrane and summoning immune cells in animal models PHILADELPHIA–A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has engineered powerful new antimicrobial molecules from toxic proteins found in wasp venom.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Common bacteria modified to make designer sugar-based drug.Envisioning an animal-free drug supply, scientists have—for the first time—reprogrammed a common bacterium to make a designer polysaccharide molecule used … Continue (..)
Pathogens don’t always work against drug treatments. Diseases caused by a combination of bacteria, viruses, fungi and parasites — also known as polymicrobial infections — are challenging to treat because scientists don’t fully understand how pathogens interact during infection and how these […].
Originally discovered in bacteria as a defense mechanism against pathogens, CRISP/Cas9 has made it possible to make exquisitely detailed and precise alterations to DNA sequences on demand, and as a tool for molecular biology has already transformed research into diseases and drug discovery. million) Nobel Prize award. “In
In this video, we chat with health policy and drug pricing researcher Hussain Lalani; Julia Joung, a molecular biologist developing genetic screening technologies; and Avinash Manjula Basavanna, who researches engineered living materials and has developed a printable ink made from bacteria.
Nirogy plans to use the proceeds to improve its drug discovery platform for generating a pipeline of small-molecule drugs designed to aim the solute carrier family of transporter proteins (SLCTs) embedded in the cell membrane. Iterum Therapeutics presents new drug application to FDA for Oral Sulopenem. Nirogy Therapeutics Inc.,
Related: Scientists Use Llama Antibodies to Neutralize COVID-19. Nanobodies are attractive therapeutic agents because of their small size and simple structure, which allow them to be more easily used as templates to design antibody drugs compared to human antibodies.
If you are developing a drug, for example, for infantile epilepsy, then you need to know if your drug target is expressed in the brain and also during early development. Likewise, some patients may have a different version of a gene with respect to people on whom a drug has been tested, which means that drug might not work.”.
Various Active Pharmaceuticals & Biotechnological Companies including Cassava Sciences, INmune Bio, Cognito Therapeutics, Cortexyme among others presented their new and upcoming drugs, therapies, shared their research studies and clinical data. An Awaited Ulcerative Colitis Phase 2 Seres Therapeutics Trial Drug Crashed Down.
Osteomyelitis is a bone infection caused by fungi or bacteria. BONESUPPORT has recently received market authorization from the US Food and Drug Administration (FDA) for Cerament G, its bone graft with antibiotic elution. Professor Lidgren is a well renowned orthopedic clinician, researcher and scientist.
Many drugs can cause dry mouth. This side effect is sometimes associated with the whole class of medicines rather than a particular drug, making dry mouth management even more critical, as there may be little room for changing the medication. List of common drugs that cause dry mouth. List of common drugs that cause dry mouth.
After spending almost an entire day deliberating the safety of Vertex Pharmaceuticals’ and CRISPR Therapeutics’ CRISPR-based gene therapy exa-cel for sickle cell disease, a US Food and Drug Administration (FDA) advisory panel appears to be satisfied with what it saw. CRISPR works as genetic scissors to edit parts of the genome.
Many drug makers are investing in new science and hope to develop new therapeutics that address autoimmune disease. Scientists will be testing a drug class targeting the C-reactive protein (CRP) marker of acute inflammation in the body. They’ll use software that searches available drugs, as well as drug-like compounds.
Golden staph are ubiquitous bacteria, living harmlessly on the skin or inside the nose of nearly one in three people worldwide. Some strains are also drug-resistant ‘superbugs,’ armed with features […] Yet they are duplicitous, too.
Bacteria plays a crucial role in maintaining the ecosystem balance. However, there are few species of bacteria that can cause several infectious diseases ( such as strep throat, salmonellosis, tuberculosis, whooping cough ). The overuse of antibiotics has resulted in the emergence of multi-drug-resistant bacteria.
TB is caused by the bacillus Mycobacterium tuberculosis and is transmitted when infected individuals expel bacteria into the air (e.g., In light of World TB day on March 24, the field hopes to overcome some major barriers to the drug development landscape. by coughing). million new cases reported worldwide.
The US Food and Drug Administration (FDA) has green-lighted the first pneumonia vaccine specifically designed for adults 50 years of age and older. Related: Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck – Xtalks Life Science Podcast Ep.
Improper disposal of antibiotics also releases these drugs into the environment, and researchers working with these drugs in the lab also have concern over their ultimate effects on study results. ” The use of low-concentration fluoride costs only about four cents per liter. ” Source link.
” The team demonstrated that life-threatening clotting could be prevented in mice infected with the bacteria E. They have shown that the mechanism involves a block in proteins called interferons, which promote tissue factor releases. coli and Staph aureus and also in response to SARS-CoV2, the virus that causes COVID-19.
Olema Oncology will assess the drug, a complete estrogen receptor antagonist, in patients with ER-positive, HER2-negative breast cancers that have come back despite other treatments or that have spread locally or to other parts of the body. The capital will bankroll a phase 1/2 study of the asset, OP-1250, as a single agent.
The US Food and Drug Administration (FDA) recognizes National Immunization Awareness Month as providing “an opportunity to think about how far the development and advancement of immunization science has come, and its impact on public health.”. Related: Menarini Diagnostics’ New COVID-19 Test Detects Variants Including Omicron.
Food and Drug Administration (FDA), and to the ecu Medicines Agency (EMA) for the treatment of adults with moderately to severely active colitis , who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent. RINVOQ 15 mg is approved within the U.S.
The revelation means that the stronger regimen could be added to a growing list of medicines discovered by accident – Alexander Fleming famously discovered penicillin after noticing a mould producing the compound was killing bacteria in a petri dish.
Meaning that a natural, drug-free remedy for gout is already known. I started with the standard meds: anti-inflammatories, steroid jabs, drugs to reduce the uric acid in my blood…. But even when a drug did do some good I knew I was just managing the condition. Scientists have long known food is a medicine.
There are several strains of bacteria that have developed resistance to different types of antibiotics — these include MRSA (methicillin-resistant Staphylococcus aureus ) Clostridium difficile ( C. diff ) and the bacteria that cause multi-drug-resistant tuberculosis. According to the WHO, the silent pandemic leads to at least 1.3
Now that scientists know what causes HCT we finally have the power to directly influence those causes. Which meant taking drugs that bind with excess iron in the blood. The chemicals in the drug make the iron less harmful – and so easier to eliminate from the body. And it’s gut bacteria that sits at the root of our HCT problem.
Some have argued bacteria are developing antibiotic resistance faster than we can research, develop, test and approve new antibiotics. One possible solution to antibiotic resistance: bacteriophages (or phages), which are viruses that infect bacteria. Antibiotic resistance is an emerging problem.
But, the way the virus is continuously mutating, is a problem for both scientists and doctors. This medicine inhibits the growth of bacteria by inhibiting the synthesis of essential proteins which is needed by the bacteria to carry out the necessary functions. An ICMR official warned about the use of this drug in the year 2020.
But, the way the virus is continuously mutating, is a problem for both scientists and doctors. This medicine inhibits the growth of bacteria by inhibiting the synthesis of essential proteins which is needed by the bacteria to carry out the necessary functions. An ICMR official warned about the use of this drug in the year 2020.
Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. billion the drug generated in 2021. billion in 2022. billion, a 26.55
Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic arthritis. The updated Prescription Drug User Fee Act (PDUFA) action date has been extended three months to late Q2 2021.
Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adults and adolescents with moderate to severe atopic dermatitis. The Prescription Drug User Fee Act (PDUFA) action date has been extended three months to early Q3 2021. .
1 The increases in blood creatine phosphokinase were non-serious and did not lead to study drug discontinuation. Discovered and developed by AbbVie scientists, RINVOQ is an oral, once daily, selective and reversible JAK inhibitor studied in several immune-mediated inflammatory diseases. 1 Serious adverse events occurred in 3.2
Food and Drug Administration (FDA) has informed the company that the FDA will not meet the Prescription Drug User Fee Act (PDUFA) action dates for the supplemental New Drug Applications (sNDAs) for RINVOQ ® (upadacitinib) for the treatment of adults with active psoriatic arthritis and adults with active ankylosing spondylitis. .
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content